Shen, C., Peng, C., Shen, B., Zhu, Z., Xu, N., Li, T., & Xie, J. (2016). Sirolimus and metformin synergistically inhibit hepatocellular carcinoma cell proliferation and improve long-term survival in patients with HCC related to hepatitis B virus induced cirrhosis after liver transplantation. Oncotarget.
Citação norma ChicagoShen, Chuan, Chenghong Peng, Baiyong Shen, Zhecheng Zhu, Ning Xu, Tao Li, and Junjie Xie. "Sirolimus and Metformin Synergistically Inhibit Hepatocellular Carcinoma Cell Proliferation and Improve Long-term Survival in Patients With HCC Related to Hepatitis B Virus Induced Cirrhosis After Liver Transplantation." Oncotarget 2016.
MLA citiranjeShen, Chuan, et al. "Sirolimus and Metformin Synergistically Inhibit Hepatocellular Carcinoma Cell Proliferation and Improve Long-term Survival in Patients With HCC Related to Hepatitis B Virus Induced Cirrhosis After Liver Transplantation." Oncotarget 2016.